Status:

COMPLETED

Naltrexone Treatment for Alcoholic Women

Lead Sponsor:

Yale University

Collaborating Sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Conditions:

Alcoholism

Eating Disorder

Eligibility:

FEMALE

18-50 years

Phase:

PHASE4

Brief Summary

This study will assess naltrexone's effectiveness in treating alcoholism in women and provide information on its potential value in treating eating disorders common among alcoholic women. Alcoholic wo...

Detailed Description

Background: Despite important gender differences in drinking patterns, physiological effects of alcohol, and co-occurring psychiatric conditions, relatively little is known about the efficacy of naltr...

Eligibility Criteria

Inclusion Criteria:

  • Meets criteria for alcohol dependence. Abstinent from alcohol for a period of at least 5 days.
  • Able to read English and complete study evaluations.
  • A stable residence and a telephone to ensure that subjects can be located during the study.

Exclusion Criteria:

  • Meets criteria for dependence on another psychoactive substance besides alcohol or nicotine.
  • Regular use of psychoactive drugs except antidepressants.
  • Current use of disulfiram (Antabuse).
  • Psychotic or otherwise severely psychiatrically disabled.
  • Significant underlying medical conditions such as cerebral, renal, thyroid, or cardiac pathology.
  • Abstinent longer than 30 days prior to admission to program.
  • Hepatocellular disease or elevated bilirubin levels.
  • Individuals with present history of opiate abuse or who require the use of opioid analgesics.
  • Women who are pregnant, nursing, or not using a reliable method of birth control.
  • Women who are significantly overweight or significantly underweight.

Key Trial Info

Start Date :

October 1 1995

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2000

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT00000448

Start Date

October 1 1995

End Date

December 1 2000

Last Update

May 7 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Substance Abuse Treatment Unit, Yale University

New Haven, Connecticut, United States, 06511

Naltrexone Treatment for Alcoholic Women | DecenTrialz